Earlier, the same group analyzed postmortem brain tissue from PD patients and found no change in the activities of MMP-9 and MMP-1 in substantia nigra, cortex, or hippocampus, whereas MMP-2 was significantly reduced in the substantia nigra. This evidence concerns the gene MMP9 and Parkinson disease.